CFO of SEER Inc. Continues Routine Tax‑Covered Share Sales, No Red Flags for InvestorsSEER CFO’s routine $2.03/share sales are tax‑driven, not bearish, keeping insider confidence high while leaving stock price stable.SEER INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 20/08/2026, 01:15 3 minutes to read
Director Dipchand’s Routine 10,660‑Share Sale at Seer Inc. Generates No Alarm, Just Routine Portfolio Adjustments.Seer Inc. insider sale: Nishar Dipchand sells 10,660 shares at $2.18, a routine Rule 10b‑5‑1 move amid bullish buzz—investors see no red flag.SEER INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 11/07/2026, 00:38 3 minutes to read
CFO Horn Sells 7,743 Shares of Seer Inc. Amidsteadily Increasing Holdings, CEO Holds 3.35M Shares in Strategic Balancing ActSeer Inc. CFO sells shares for tax planning, but retains 0.44% stake, signaling confidence amid biotech growth and upcoming conference news.SEER INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 19/02/2026, 22:36 3 minutes to read